4
Changes in Ownership
Imunon, Inc. Filed Acc 0001437749-22-015057
Options or other derivatives
- Chairman, President and CEO acquired 90,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tardugno Michael H Chairman, President and CEO | 2022-06-13 | Grant or award · Option to Purchase Celsion Common Stock | +90,000 | 303,068 | D: show line 1 in the form |
Loading xslF345X03/rdgdoc.xml…